Neuphoria Therapeutics (NEUP) Non-Current Assets (2021 - 2025)
Historic Non-Current Assets for Neuphoria Therapeutics (NEUP) over the last 5 years, with Q4 2025 value amounting to $13.2 million.
- Neuphoria Therapeutics' Non-Current Assets fell 405.41% to $13.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $53.8 million, marking a year-over-year change of. This contributed to the annual value of $13.5 million for FY2025, which is N/A changed from last year.
- According to the latest figures from Q4 2025, Neuphoria Therapeutics' Non-Current Assets is $13.2 million, which was down 405.41% from $13.4 million recorded in Q3 2025.
- Over the past 5 years, Neuphoria Therapeutics' Non-Current Assets peaked at $16.9 million during Q4 2021, and registered a low of $13.2 million during Q4 2025.
- In the last 5 years, Neuphoria Therapeutics' Non-Current Assets had a median value of $13.8 million in 2024 and averaged $14.6 million.
- Per our database at Business Quant, Neuphoria Therapeutics' Non-Current Assets plummeted by 903.83% in 2023 and then tumbled by 405.41% in 2025.
- Neuphoria Therapeutics' Non-Current Assets (Quarter) stood at $16.9 million in 2021, then decreased by 0.6% to $16.8 million in 2022, then fell by 9.04% to $15.3 million in 2023, then fell by 10.07% to $13.8 million in 2024, then dropped by 4.05% to $13.2 million in 2025.
- Its last three reported values are $13.2 million in Q4 2025, $13.4 million for Q3 2025, and $13.5 million during Q2 2025.